A Family's Heart-Warming Meeting With Recipient of Son's Organ Donation

A 26-year-old student was saved with a lung transplant after battling cystic fibrosis.
Source: ABC News: Health - Category: Consumer Health News Tags: Health Source Type: news

Related Links:

We report practice patterns and outcomes for pediatric LTx in CF and non-CF patients.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 122 Source Type: research
Bacteriophages are host-specific lytic viruses that are of increasing interest as adjunctive therapy for treatment of multi-drug resistant (MDR) pathogens.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 69 Source Type: research
The primary driver of poor outcomes in the early stages of lung transplantation is primary graft dysfunction (PGD). Patients with cystic fibrosis (CF) have unique physiology and demographics compared to other lung transplant recipients. Therefore, we sought to identify risk factors for PGD in the CF patient population undergoing lung transplantation.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 342 Source Type: research
Exophiala dermatitidis is a black fungus that frequently colonises the lungs of people with cystic fibrosis (CF). Mucoid and non-mucoid variants can be detected from the same sputum for some patients, but their role in chronic CF lung disease is not fully understood and attempts at early eradication are not routinely performed. Invasive infections with this species are rare; however in 2014 we reported our first case of fatal, invasive infection with a highly mucoid strain of E. dermatitidis in a 34 year old post lung transplant patient with CF.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 787 Source Type: research
Lung transplantation is an accepted therapy for patients with end stage lung disease due to Cystic Fibrosis (CF). Up to ten percent of patients with CF are colonized with Achromobacter xylosoxidans, a gram negative organism that due to its intrinsic resistance to many antibiotics may affect negatively impact post-transplant outcomes.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 784 Source Type: research
This study, in a project funded by the Cystic Fibrosis Lung Transplant Consortium, examined candidates understanding and concerns in each of these domains.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 752 Source Type: research
Distal intestinal obstruction syndrome (DIOS) is a debilitating condition which is unique to Cystic Fibrosis (CF). Constipation is increasingly common in CF patients as a result of the altered fluid composition of the intestine caused by the CF transmembrane conductance regulator gene defect. The incidence of both DIOS and constipation is increased in CF-patients post lung transplant1-2.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 740 Source Type: research
To identify novel variables associated with waitlist (WL) and posttransplant (PT) mortality for cystic fibrosis (CF) lung transplant patients. To analyze the impact of including new variables in the lung allocation score (LAS) system.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 844 Source Type: research
The objective of these guidelines is to provide recommendations to the CF community to enhance identification and timely referral of individuals with CF who could benefit from LTx, as well as to encourage partnerships between CF Centers and LTx Centers to improve the referral process.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: 830 Source Type: research
We have read with great interest the case report by Pujol et al entitled Synchronous multiple non-small cell lung cancers in an allograft lung recipient [1], about a young cystic fibrosis lung transplant recipient who developed metastatic lung cancer. We would like to comment on this ‘rare’ long-term complication post lung transplantation. Recent registry data from the International Society of Heart and Lung Transplantation showed that the overall incidence of a malignancy post lung transplantation at 1, 5 and 10 years is 5.3%, 19.6% and 31.7% respectively [2] In observation al studies the incidence of lung can...
Source: Lung Cancer - Category: Cancer & Oncology Authors: Source Type: research
More News: Cardiology | Cystic Fibrosis | Health | Heart | Heart Transplant | Lung Transplant | Students | Transplant Surgery | Transplants | Universities & Medical Training